Clinical Research

Are We on the Brink of a Health Revolution in Cardiometabolic Health?

Obesity-related heart disease deaths are rising fast, but breakthroughs in research and care are offering new hope.

Beyond the Scale: Navigating Weight and Wellness

Patients who discuss weight directly with their doctor are 32% more likely to lose meaningful weight within a year.

Fighting the Obesity Epidemic: Strategies for Healthier Lives

US obesity rates dropped from 41.9% to 40.3% — a promising sign that new medications and strategies are making an impact.

Bringing Early Psychoeducation to the Forefront of Obesity Care at LM24

Enara Health showcases early psychoeducation's role in obesity care at the 2024 Lifestyle Medicine Conference, emphasizing personalized, stigma-free, data-driven weight management.

Compounded GLP-1 medications are becoming common during shortages, but not all sources are safe — here's what to know.

New Solutions for Rising Obesity Rates

With obesity rates over 35% in 23 states, new research breakthroughs offer real hope for turning the tide.

Health Reimagined: New Discoveries

From tirzepatide's diabetes prevention power to personalized care models, new discoveries are transforming obesity treatment.

Obesity 2.0: New Wave of Science-Backed, Personalized Health

The future of obesity care goes beyond the scale — considering body composition, psychology, and individual medical needs.

GLP-1 and Integrated Treatments in Obesity Care

GLP-1 therapies are showing incredible potential, but the best outcomes come from integrating them with lifestyle changes.

The 'Beta Diet Plan': How Exercise and Weight Loss Play a Role in Your Metabolic Health

New research reveals how exercise during weight loss uniquely improves beta cell function — the cells that regulate blood sugar.

From Trial to Treatment: Obesity Medications in Everyday Medical Practice

Clinical trial results for obesity medications are impressive, but real-world outcomes tell a different, more nuanced story.

Cholesterol Reduction: A Wave of Exciting Developments

Two new studies and an FDA approval are reshaping cholesterol management toward more personalized approaches.